Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.ppat.1009331
Title: Antibody affinity versus dengue morphology influences neutralization
Authors: Fibriansah, Guntur 
Lim, Elisa X. Y. 
Marzinek, Jan K.
Ng, Thiam-Seng 
Tan, Joanne L. 
Huber, Roland G.
Lim, Xin-Ni 
Chew, Valerie S. Y. 
Kostyuchenko, Victor A. 
Shi, Jian 
Anand, Ganesh S. 
Bond, Peter J. 
Crowe, James E.
Lok, Shee-Mei 
Issue Date: 23-Feb-2021
Publisher: Public Library of Science
Citation: Fibriansah, Guntur, Lim, Elisa X. Y., Marzinek, Jan K., Ng, Thiam-Seng, Tan, Joanne L., Huber, Roland G., Lim, Xin-Ni, Chew, Valerie S. Y., Kostyuchenko, Victor A., Shi, Jian, Anand, Ganesh S., Bond, Peter J., Crowe, James E., Lok, Shee-Mei (2021-02-23). Antibody affinity versus dengue morphology influences neutralization. PLoS Pathogens 17 (2) : e1009331. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.ppat.1009331
Rights: Attribution 4.0 International
Abstract: Different strains within a dengue serotype (DENV1-4) can have smooth, or “bumpy” surface morphologies with different antigenic characteristics at average body temperature (37C). We determined the neutralizing properties of a serotype cross-reactive human monoclonal antibody (HMAb) 1C19 for strains with differing morphologies within the DENV1 and DENV2 serotypes. We mapped the 1C19 epitope to E protein domain II by hydrogen deuterium exchange mass spectrometry, cryoEM and molecular dynamics simulations, revealing that this epitope is likely partially hidden on the virus surface. We showed the antibody has high affinity for binding to recombinant DENV1 E proteins compared to those of DENV2, consistent with its strong neutralizing activities for all DENV1 strains tested regardless of their morphologies. This finding suggests that the antibody could out-compete E-to-E interaction for binding to its epitope. In contrast, for DENV2, HMAb 1C19 can only neutralize when the epitope becomes exposed on the bumpy-surfaced particle. Although HMAb 1C19 is not a suitable therapeutic candidate, this study with HMAb 1C19 shows the importance of choosing a high-affinity antibody that could neutralize diverse dengue virus morphologies for therapeutic purposes. Copyright: © 2021 Fibriansah et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Source Title: PLoS Pathogens
URI: https://scholarbank.nus.edu.sg/handle/10635/233760
ISSN: 1553-7366
DOI: 10.1371/journal.ppat.1009331
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_ppat_1009331.pdf7.08 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons